029-83533393
   info@TaiBSbio.com
 
组织芯片,组织微阵列
 
RLN1202肺癌及正常组织组合芯片,附病理分级、TNM、临床分期,120例/120点
点 数120例 数120
行 数10列 数12
点直径(mm)1.0厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.

产品名:RLN1202
 
肺癌及正常组织微阵列芯片,包含鳞状细胞癌40例,腺鳞癌3例,腺癌52例,大细胞癌3例,小细胞癌8例,类癌4例,正常组织10例,一例一点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Lun
-Lung
 
Malignant (IA1)
 
Malignant (IA2)
 
Malignant (IB)
 
Malignant (IIA)
 
Malignant (IIB)
 
Malignant (IIIA)
 
Malignant (IIIB)
 
Malignant (IV)
 
Normal (*)
TISSUE  ARRAYS RLN1202
1
2
3
4
5
6
7
8
9
10
11
12
A
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
B
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
C
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
D
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
E
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
F
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
G
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
H
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
I
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
J
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeTumor SizeisBackUp
A1153MLungSquamous cell carcinoma1T2N0M0IBMalignant3*3*3N
A2267MLungSquamous cell carcinoma1--2T2N0M0IBMalignant4*3.5*3N
A3341MLungSquamous cell carcinoma2T2N0M0IBMalignant4*3*2N
A4445MLungSquamous cell carcinoma2T2aN0M0IBMalignant*N
A5568MLungSquamous cell carcinoma (sparse)2T2N2M0IIIAMalignant*N
A6641MLungSquamous cell carcinoma2T2N2M0IIIAMalignant*N
A7769MLungSquamous cell carcinoma with necrosis2T2N2M0IIIAMalignant*N
A8848MLungSquamous cell carcinoma with necrosis2T2N1M0IIBMalignant4*3*3N
A9955MLungSquamous cell carcinoma2T4N1M0IIIAMalignant3*2*1.5N
A101055MLungSquamous cell carcinoma2T2N1M0IIBMalignant5.0*4.0*3.5N
A111161MLungSquamous cell carcinoma2T2N0M0IBMalignant*N
A121269MLungSquamous cell carcinoma2T2N1M0IIBMalignant4*4*3N
B11360MLungSquamous cell carcinoma with necrosis2T2N0M0IBMalignant*N
B21460FLungSquamous cell carcinoma2T2N1M0IIBMalignant5*4*4N
B31545MLungSquamous cell carcinoma2T4N1M0IIIAMalignant*N
B41655MLungSquamous cell carcinoma with necrosis2T2bN0M0IIAMalignant*N
B51762MLungSquamous cell carcinoma2T2bN1M0IIBMalignant*N
B61850MLungSquamous cell carcinoma2T2aN1M0IIBMalignant*N
B71956FLungSquamous cell carcinoma2--3T2N2M0IIIAMalignant3.5*3*2N
B82066MLungSquamous cell carcinoma2--3T2bN0M0IIAMalignant4.0*4.0*2.5N
B92163MLungSquamous cell carcinoma with necrosis2--3T2N2M0IIIAMalignant*N
B102265MLungSquamous cell carcinoma2--3T2aN0M0IBMalignant*N
B112366MLungSquamous cell carcinoma2--3T2aN0M0IBMalignant*N
B122450FLungSquamous cell carcinoma2--3T2aN0M0IBMalignant*N
C12561MLungSquamous cell carcinoma with necrosis3T2N0M0IBMalignant*N
C22664MLungSquamous cell carcinoma3T2bN3M0IIIBMalignant5.5*4.0*3.5N
C32755MLungSquamous cell carcinoma with necrosis3T2aN0M0IBMalignant*N
C42861MLungSquamous cell carcinoma3T2N0M0IBMalignant*N
C52956MLungSquamous cell carcinoma3T2N1M0IIBMalignant*N
C63043FLungSquamous cell carcinoma3T2N1M0IIBMalignant*N
C73164FLungSquamous cell carcinoma3T2N0M0IBMalignant*N
C83254MLungSquamous cell carcinoma3T1bN1M0IIBMalignant3*3*2.5N
C93363MLungSquamous cell carcinoma with necrosis3T2bN1M0IIBMalignant*N
C103456MLungSquamous cell carcinoma with necrosis3T1N2M0IIIAMalignant*N
C113551FLungSquamous cell carcinoma3T2N2M0IIIAMalignant*N
C123646MLungSquamous cell carcinoma with necrosis3T2N0M0IBMalignant*N
D13763MLungSquamous cell carcinoma with necrosis3T2N1M0IIBMalignant*N
D23862MLungSquamous cell carcinoma3T2aN1M0IIBMalignant5*5*4N
D33965MLungSquamous cell carcinoma3T2N0M0IBMalignant4*4*3N
D44071MLungSquamous cell carcinoma3T1bN0M0IA2Malignant*N
D54152FLungAdenosquamous carcinoma*T3N1M0IIIAMalignant*N
D64254FLungAdenosquamous carcinoma*T3N1M0IIIAMalignant*N
D74366MLungAdenosquamous carcinoma*T2aN0M0IBMalignant*N
D84448MLungAdenocarcinoma (sparse)1T1aN0M0IA1Malignant3*3*3N
D94554FLungAdenocarcinoma1T2N0M0IBMalignant*N
D104651MLungMucinous adenocarcinoma1--2T4N2M0IIIBMalignant*N
D114754MLungAdenocarcinoma2T3N1M0IIIAMalignant8*6.5*6N
D124848FLungAdenocarcinoma2T2N0M0IBMalignant*N
E14959MLungAdenocarcinoma with necrosis2T2bN0M0IIAMalignant*N
E25067MLungAdenocarcinoma2T2aN0M0IBMalignant4.0*2.5*2.0N
E35151MLungAdenocarcinoma2T3N1M0IIIAMalignant*N
E45263FLungAdenocarcinoma2T2aN1M0IIBMalignant*N
E55351FLungAdenocarcinoma2T2N0M0IBMalignant*N
E65462MLungPapillary adenocarcinoma2T2aN0M0IBMalignant4.0*3.5*3.0N
E75567MLungAdenocarcinoma with necrosis2T2aN1M0IIBMalignant*N
E85656FLungAdenocarcinoma2T1bN0M0IA2Malignant*N
E95771FLungAdenocarcinoma2T2N1M0IIBMalignant*N
E105870MLungAdenocarcinoma with necrosis2T2N0M0IBMalignant*N
E115957MLungAdenocarcinoma (sparse)2T2N1M0IIBMalignant*N
E126062MLungAdenocarcinoma2T2aN0M0IBMalignant4.5*4.0*3.0N
F16161FLungAdenocarcinoma2T2bN1M0IIBMalignant*N
F26268FLungAdenocarcinoma with necrosis2T3N1M0IIIAMalignant*N
F36366MLungAdenocarcinoma2T2aN1M0IIBMalignant*N
F46454%ELungAdenocarcinoma2T2bN2M0IIIAMalignant*N
F56568MLungAdenocarcinoma2T2bN1M0IIBMalignant*N
F66639FLungAdenocarcinoma with necrosis2T2aN0M0IBMalignant*N
F76764FLungAdenocarcinoma2T2aN0M0IBMalignant*N
F86841MLungPapillary adenocarcinoma2T2aN0M0IBMalignant4.5*4.0*3.0N
F96936FLungAdenocarcinoma with neuroendocrine differentiation2T2aN0M0IBMalignant*N
F107048MLungInvasive adenocarcinoma2T2N1M0IIBMalignant*N
F117160MLungAdenocarcinoma with necrosis2T2N1M0IIBMalignant*N
F127249MLungPapillary adenocarcinoma with necrosis2T2N0M0IBMalignant5.0N
G17359FLungAdenocarcinoma2T3N1M0IIIAMalignant*N
G27448FLungAdenocarcinoma with necrosis2--3T2aN0M0IBMalignant4*3*2.5N
G37547MLungMucinous adenocarcinoma2--3T2aN0M0IBMalignant*N
G47668MLungAdenocarcinoma2--3T2aN0M0IBMalignant*N
G57757MLungAdenocarcinoma with necrosis2--3T2aN0M0IBMalignant*N
G67868MLungAdenocarcinoma2--3T2N1M1IVMalignant*N
G77950MLungAdenocarcinoma3T2bN1M0IIBMalignant*N
G88061MLungAdenocarcinoma2T2aN0M0IBMalignant4.0*3.5*3.0N
G98160MLungAdenocarcinoma3T2N2M0IIIAMalignant*N
G108266MLungAcinar adenocarcinoma3T2bN0M0IIAMalignant*N
G118335FLungAdenocarcinoma3T2aN0M0IBMalignant*N
G128448MLungAdenocarcinoma2--3T2aN0M0IBMalignant*N
H18576MLungAdenocarcinoma3T2N1M0IIBMalignant*N
H28653MLungAdenocarcinoma with necrosis3T2aN0M0IBMalignant*N
H38759MLungAdenocarcinoma3T2bN1M0IIBMalignant*N
H48870MLungSolid adenocarcinoma (sparse)3T2bN0M0IIAMalignant5.5*4*3.5N
H58965MLungAdenocarcinoma3T3N0M0IIBMalignant*N
H69060MLungAdenocarcinoma (sparse)3T2aN1M0IIBMalignant*N
H79156FLungAdenocarcinoma with necrosis3T2aN1M0IIBMalignant7*5*3.5N
H89261MLungSolid adenocarcinoma3T2bN1M0IIBMalignant*N
H99372MLungAdenocarcinoma (sparse)3T1aN0M0IA1Malignant*N
H109448MLungAdenocarcinoma3T3N1M0IIIAMalignant4.0N
H119557FLungAcinar adenocarcinoma with necrosis3T2aN0M0IBMalignant*N
H129647FLungLarge cell carcinoma with necrosis (sparse)*T2N2M0IIIAMalignant*N
I19757FLungLarge cell carcinoma*T2aN0M0IBMalignant*N
I29864MLungLarge cell carcinoma*T2aN0M0IBMalignant*N
I39956MLungSmall cell carcinoma with necrosis*T3N1M0IIIAMalignant*N
I410052MLungSmall cell carcinoma with necrosis*T2aN0M0IBMalignant4.0N
I510161MLungSmall cell carcinoma*T2aN0M0IBMalignant3.5*3*0.7N
I610239MLungSmall cell carcinoma*T2N1M0IIBMalignant*N
I710342FLungSmall cell carcinoma*T4N1M0IIIAMalignant*N
I810457MLungSmall cell carcinoma*T2bN0M0IIAMalignant4.5*4.5*3.0N
I910544MLungSmall cell carcinoma*T2bN1M0IIBMalignant*N
I1010652MLungSmall cell carcinoma*T2N0M0IBMalignant4*5N
I1110760MLungAtypical carcinoid*T1aN0M0IA1Malignant*N
I1210836FLungAtypical carcinoid*T2aN0M0IBMalignant*N
J110949MLungAtypical carcinoid*T4N2M0IIIBMalignant*N
J211043MLungCarcinoid*T2aN0M0IBMalignant*N
J311147MLungLung tissue (mild inflammation)***Normal*N
J411224MLungLung tissue (mild inflammation)***Normal*N
J511325FLungLung tissue (mild inflammation)***Normal*N
J611419MLungLung tissue (chronic inflammation)***Normal*N
J711555MLungLung tissue (mild inflammation)***Normal*N
J811645FLungLung tissue (mild inflammation)***Normal*N
J911748MLungLung tissue (mild inflammation)***Normal*N
J1011830MLungLung tissue (mild inflammation)***Normal*N
J1111943MLungLung tissue (mild inflammation)***Normal*N
J1212040FLungLung tissue (mild inflammation)***Normal*N
Tissue Marker
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址:陕西西安市灞桥区长乐东路2999号
电话:029-83533393, 17792711553,
电子邮箱:taibsbio@163.com
QQ:3144647811
微信号:13002913390
邮政编码:710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售,加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队,并且具有庞大的组织标本库。样本库中组织微阵列种类多,病理类型齐全,同时根据客户需求情况进行制作加工新的组织微阵列,尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度,致力于为广大客户提供质量好的产品和优质的服务。

更多详情